Literature DB >> 14594505

Colony-stimulating activity of fetal liver cells: synergistic role of stem cell factor in bone marrow recovery from aplastic anemia.

G M K Raju1, S Guha, A Mukhopadhyay, L Kumar, V P Kale, S Mittal, D Deka, S Mohanty, V Kochupillai.   

Abstract

Previously, we and others have shown that fetal liver infusion (FLI) leads to autologous hematopoietic improvement in 40-54% of patients with aplastic anemia. However, whether this recovery was spontaneous or the effect of the infused liver cells was not clear. To dissect the role of FLI in autologous hematopoietic recovery, the colony-supporting potential of fetal liver-conditioned medium (FLCM) was evaluated in bone marrow (BM) cells of normal adult and aplastic anemia patients. In both cases, each sample of FLCM supported the growth of colony-forming cells in semi solid culture medium. The FLCM was assayed for the presence of four principal colony-stimulating cytokines, namely stem cell factor (SCF), granulocyte-macrophage colony-stimulating factor (GM-CSF), interleukin-3 (IL-3), and erythropoietin (Epo). While GM-CSF, IL-3, and Epo were present in insignificant amounts or were altogether absent, 50-635 pg/ml of SCF was found in 8 of the 13 FLCM samples tested. Preliminary results of bioneutralization assay indicated the possible role of SCF, secreted by the FL cells, in colony-supporting activity of aplastic anemia and normal BM cells. Overall, our in vitro study implicates the paracrine role of infused FL cells in regenerating autologous hematopoiesis in aplastic anemia patients.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14594505     DOI: 10.1089/152581603322448196

Source DB:  PubMed          Journal:  J Hematother Stem Cell Res        ISSN: 1525-8165


  1 in total

1.  Human granulocyte-colony stimulating factor (G-CSF)/stem cell factor (SCF) fusion proteins: design, characterization and activity.

Authors:  Gitana Mickiene; Indrė Dalgėdienė; Gintautas Zvirblis; Zilvinas Dapkunas; Ieva Plikusiene; Ernesta Buzavaite-Verteliene; Zigmas Balevičius; Audronė Rukšėnaitė; Milda Pleckaityte
Journal:  PeerJ       Date:  2020-08-21       Impact factor: 2.984

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.